Transcription of FINAL CLINICAL STUDY REPORT
{{id}} {{{paragraph}}}
MAPS CLINICAL STUDY REPORT MP-2 15-SEP-2011 Page 1 of 62 FINAL CLINICAL STUDY REPORT Protocol #: MP- 2 IND #: 63,384 September 15, 2011 First Subject First Visit: July 18, 2006 Last Subject Last Visit: January 10, 2011 Phase Two Pilot STUDY : 3,4-methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy in Patients with Treatment-resistant Posttraumatic Stress Disorder (PTSD) A randomized, single-center, active placebo-controlled, double-blind, partial crossover STUDY comparing response to psychotherapy assisted by 25mg or 125 mg MDMA. A STUDY performed in accordance with the principles of Good CLINICAL Practice as described in International Conference of Harmonization guidelines, including the archiving of essential documents.
MAPS Clinical Study Report MP-2 15-SEP-2011 MP-2_CSR_FINAL_15SEP11.pdf Page 1 of 62 FINAL CLINICAL STUDY REPORT Protocol #: MP- 2 IND #: 63,384
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Stress and the 911 Dispatcher, First, Responders, CRISIS TEAM RESOURCE GUIDE: READINESS, RESPONSE, Traumatic events, Statement of Principles concerning posttraumatic, Statement of Principles concerning POSTTRAUMATIC STRESS DISORDER, Recommendations for Diagnosing a Mild Traumatic, Traumatic, Bleeding Control, Events